But it's an excellent reason to pump...especially for the road kill who bought near 4 1/2, and the game boys who trade in and out towards 0 basis.
In the meantime, the largest part of the i/p of all these dogs is about to depreciate 80%, as an actual praxis for autologuous regenerative strategy gets cheaper to do and cheaper to maintain than the Frankenbabble of the corspiscle cultists.
Rotfl.... Every time you get called out for your failure to learn to read a filing you go for the ad hom.
Neal has been playing Biotime since 97 or 98.
The fact that Neal holds a lot of BTX indicates no more than Neal owns a lot of BTX. So, how much does Icahn--AK's old partner--own? How much of CALPERS is in BTX? The fact that you continue to ignore questions like that makes your blatantly obvious agenda--pumping this dog--evident.
"Bullish"???? Form WHOM? Hint: it's not Jmil2, who just got diluted again.
REally? When you arrived here you were a "science teacher." --One who can;t do middle school math, read a filing, or follow a paper trail 10 minutes deep. That was around 4 3/8.
Around 3 1/4 there's likely to be a bounce back to 3 3/4 on some or another form of totally bogus "news."
Call it 6 months to get it done--or less. That's 1/2 on a 3 1/4 capital tie--which is around 30% APR.
Way better than WB's batting average.
OR--reasonable way to lower your basis on all the underwater shares you hold.
Rinse and repeat, rinse and repeat, and you might end up with a basis like that of insiders and their cronies--which is the only time "insider buys" or ownership actually matter to people who can play this game.
When? When BTX runs low on cash and wants to create the illusion that it is not diluting.
" We are presently a subsidiary of BioTime. As of the date of this prospectus, BioTime owns 21,823,340 Series B Shares, comprising approximately 71.6% of the outstanding common stock, and owns warrants to purchase an additional 3,150,000 Series B Shares. After the completion of this offering, BioTime will own approximately ___ % of the outstanding common stock if the underwriter does not exercise its over-allotment option, or approximately __% of the outstanding common stock if the underwriter’s over-allotment option is exercised in full.
The number of Series A Shares that will be outstanding immediately after this offering is based on 6,537,779 shares outstanding as of November 1, 2013 and excludes the conversion of any Series B Shares into Series A Shares."
At which point prudent speculators will be anticipating a massive agora/mauldin/cox/pennysleuth pump.
That's unlikely by the end of 2015. Your broker forgot that the tools he is using would already have btx at 1ish.
Not to mention, btx has been there before, and all the $$ in the ticker have come from playing it, not owning it, as it went from !/2 @ 3mm o/s to 77; thence back to 1/8 at 22mm; thence to 9 7/8 @ around 32 mm....now wonding back down based on the ever shrinking odds that btx can ever achieve $0.01 ebitda--which would put it around? 7/16 to 1.
search : profits-without-social-benefit for a set of pfretty graphs showing how AAPL are parasites.
Want the economy to "pcik up"?
Tax all revenue sources at the same present max rate.
Raise the standard exemption to 133% of the Federal "poverty level"
stay the course until the "debt" is back to $6 trillion or so.
The n start tapering the max rate.
By changing the number of people who understand the "experts" are no different than Jordan Belfort, and statistically speaking, no more accurate than a dart board or a chimpanzee with a typewriter.
Or--as I noted 3 years ago, what prints is what is..tho there can be stories told about "why" it will print somewhere else someday.
Good to see you about. This is very useful news. ACTC--ipo @ 6 with mikey at the helm, a dozen years later, 2.5billion issued, trading at 1/16, with a near concrete wall at 3/32--and only holding that after paying the SEC $4mm to get a "no admission of guilt" card so it could keep playing.
And nobody has ever taken me up on the challenge of doing a fact-checkable 3 year plan to get ACTC to $0.00001 per share ebitda...let alone GAAP.
Fairly soon I'll be able to start the same challenge on BTX...at $0.001....which is where i started it with ACTC in 2007.
Road kill necessarily forgets this is not a "science" play---it's an equity play.
My consistent advice here has been learn to play the phleaping game, or be road kill and like it. For most, that means stop thinking that buying a ticket to a game makes you a player on the field.
This most recent of a nearly endless p&d cycles at Agora should teach anyone who actually wanted to learn.
Exccellelent to see you about. Trust you have been well and prosperous. Improved spell check balances the damage caused by 8-10,000 hours having CRTs burn the eyes. Using mReits, let's say starting April 09 does produce tasty enough results... but I personally prefer MLPs for that kind of thing. I see fair exposure in the "recovered" markets to froth (San Fancisco real estate up 30% ??? Shudder...
A failing recall has lost the tickers, but if you look around you can find a couple of ETFs directly in the MLP space. Also, the January? Fortune mentions a Mexican REIT that sounded tasty.
The retail road kill here is past caring about--having gone to koolade every one--but 'splaining to newbies how the game is played still provides reasons to post around here.
After $@0mm or so burn, BTX now has a "me, too" product in limited use in EEU that will liklely trutn less than $10k a year, is in the process of a "me,too" cancer test (where one of the two present players went bk before getting the r&d back) and a couple of other "me,too" in soon to be obsolete technology on cancer.
THat is, yeah--the same as Hextend. Hextend works. Period. A 10 year study by the Pentagon determined the cost/benefit analysis in "health outcome" is there--as long as use is limited and the price point from Hospira is such that royalties to BTX are under $50k a year.
BTX has major potential to do that over and over again---advancing "science" with all costs paid by dilution to the retail road kill. The "insiders" and cronies are all in at a 1/8 or less net...so any price that keeps this dog listed is pure gravy.
Then donate to it.
O wait... you have been.
Thus far, as measnured against a random walk, about 60% of your spend.
Which it will attempt to show is the equivalent of others already on the mkt.
And thence put out press releases (that the FDA doesn't read) claiming it's better.
Without anybody talking about who pays what for what.
Simple--the people who knew the "news" was coming were the same people buying a few weeks ago,
and selling the "rally" to the retail cannon fodder--which is beginning to wise up.